Menu
GeneBe

rs190177286

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000435.3(NOTCH3):c.2411-4C>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00451 in 1,613,688 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/2 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0029 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0047 ( 27 hom. )

Consequence

NOTCH3
NM_000435.3 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.00004076
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.0390
Variant links:
Genes affected
NOTCH3 (HGNC:7883): (notch receptor 3) This gene encodes the third discovered human homologue of the Drosophilia melanogaster type I membrane protein notch. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signalling pathway that plays a key role in neural development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remains to be determined. Mutations in NOTCH3 have been identified as the underlying cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 19-15184454-G-C is Benign according to our data. Variant chr19-15184454-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 256128.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-15184454-G-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.00468 (6843/1461388) while in subpopulation NFE AF= 0.00552 (6142/1111762). AF 95% confidence interval is 0.00541. There are 27 homozygotes in gnomad4_exome. There are 3361 alleles in male gnomad4_exome subpopulation. Median coverage is 35. This position pass quality control queck.
BS2
High AC in GnomAd at 438 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NOTCH3NM_000435.3 linkuse as main transcriptc.2411-4C>G splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000263388.7
NOTCH3XM_005259924.5 linkuse as main transcriptc.2410+452C>G intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NOTCH3ENST00000263388.7 linkuse as main transcriptc.2411-4C>G splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_000435.3 P1
NOTCH3ENST00000601011.1 linkuse as main transcriptc.2407+452C>G intron_variant 5

Frequencies

GnomAD3 genomes
AF:
0.00288
AC:
438
AN:
152182
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00210
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.00160
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00497
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.00342
AC:
855
AN:
250114
Hom.:
3
AF XY:
0.00341
AC XY:
461
AN XY:
135334
show subpopulations
Gnomad AFR exome
AF:
0.000987
Gnomad AMR exome
AF:
0.00156
Gnomad ASJ exome
AF:
0.000398
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00307
Gnomad FIN exome
AF:
0.00126
Gnomad NFE exome
AF:
0.00572
Gnomad OTH exome
AF:
0.00246
GnomAD4 exome
AF:
0.00468
AC:
6843
AN:
1461388
Hom.:
27
Cov.:
35
AF XY:
0.00462
AC XY:
3361
AN XY:
726998
show subpopulations
Gnomad4 AFR exome
AF:
0.000508
Gnomad4 AMR exome
AF:
0.00143
Gnomad4 ASJ exome
AF:
0.000306
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00332
Gnomad4 FIN exome
AF:
0.00178
Gnomad4 NFE exome
AF:
0.00552
Gnomad4 OTH exome
AF:
0.00378
GnomAD4 genome
AF:
0.00288
AC:
438
AN:
152300
Hom.:
1
Cov.:
32
AF XY:
0.00248
AC XY:
185
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.00101
Gnomad4 AMR
AF:
0.00209
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000829
Gnomad4 FIN
AF:
0.00160
Gnomad4 NFE
AF:
0.00497
Gnomad4 OTH
AF:
0.00237
Alfa
AF:
0.00368
Hom.:
0
Bravo
AF:
0.00287
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00463
EpiControl
AF:
0.00379

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenFeb 01, 2024NOTCH3: BP4, BS1, BS2 -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingInvitaeJan 22, 2024- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 30, 2023- -
NOTCH3-related condition Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesAug 24, 2021This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Lateral meningocele syndrome;C3809084:Myofibromatosis, infantile, 2;C4551768:Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsSep 19, 2021- -
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
Cadd
Benign
0.25
Dann
Benign
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000041
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs190177286; hg19: chr19-15295265; COSMIC: COSV54638045; COSMIC: COSV54638045; API